Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Sep 21, 2023

BUY
$2.19 - $3.98 $72,708 - $132,136
33,200 Added 73.94%
78,100 $193,000
Q2 2022

Aug 15, 2022

BUY
$2.19 - $3.98 $72,708 - $132,136
33,200 Added 73.94%
78,100 $194,000
Q1 2022

Sep 21, 2023

BUY
$3.28 - $7.12 $48,872 - $106,088
14,900 Added 49.67%
44,900 $171,000
Q1 2022

May 16, 2022

BUY
$3.28 - $7.12 $48,872 - $106,088
14,900 Added 49.67%
44,900 $172,000
Q4 2021

Sep 21, 2023

BUY
$6.55 - $13.25 $196,500 - $397,500
30,000 New
30,000 $199,000
Q4 2021

Feb 14, 2022

BUY
$6.55 - $13.25 $196,500 - $397,500
30,000 New
30,000 $200,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $109M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.